BIOMAT Database Logo BIOMAT Database Logo

Intracerebroventricular administration of GM1 ganglioside to presenile Alzheimer patients. 1997

L E Augustinsson, and K Blennow, and C Blomstrand, and G Bråne, and R Ekman, and P Fredman, and I Karlsson, and M Kihlgren, and W Lehmann, and A Lekman, and J E Månsson, and I Ramström, and A Wallin, and C Wikkelsö, and C G Gottfries, and L Svennerholm
Department of Clinical Neuroscience, Göteborg University, Sweden.

We have conducted a preliminary study of the optimum conditions for a therapeutic effect of ganglioside GM1 in Alzheimer's disease. Five patients with the early onset form of Alzheimer's disease (AD type I) received the ganglioside by intracerebroventricular administration for 12 months. Bilateral stereotactic punction of the frontal horns of the ventricular system was performed, and shunt catheters were implanted and connected to a programmable pump. The optimum GM1 dose varied between 20 and 30 mg/24 h. Neurological neuropsychological, psychiatric and neurochemical examinations were performed 7 days before surgery and on days 30, 90, 180 and 360. No patient found the surgery difficult and no patient or relative regretted that they participated in the study. The patients became more active and safer in relation to others and to performance of various activities from day 90. The cerebrospinal fluid level of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid and the neuropeptide somatostatin increased.

UI MeSH Term Description Entries
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D002560 Cerebrovascular Circulation The circulation of blood through the BLOOD VESSELS of the BRAIN. Brain Blood Flow,Regional Cerebral Blood Flow,Cerebral Blood Flow,Cerebral Circulation,Cerebral Perfusion Pressure,Circulation, Cerebrovascular,Blood Flow, Brain,Blood Flow, Cerebral,Brain Blood Flows,Cerebral Blood Flows,Cerebral Circulations,Cerebral Perfusion Pressures,Circulation, Cerebral,Flow, Brain Blood,Flow, Cerebral Blood,Perfusion Pressure, Cerebral,Pressure, Cerebral Perfusion
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D005677 G(M1) Ganglioside A specific monosialoganglioside that accumulates abnormally within the nervous system due to a deficiency of GM1-b-galactosidase, resulting in GM1 gangliosidosis. GM1 Ganglioside,Monosialosyl Tetraglycosyl Ceramide,GM1a Monosialoganglioside,Ceramide, Monosialosyl Tetraglycosyl,Ganglioside, GM1,Monosialoganglioside, GM1a,Tetraglycosyl Ceramide, Monosialosyl
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

L E Augustinsson, and K Blennow, and C Blomstrand, and G Bråne, and R Ekman, and P Fredman, and I Karlsson, and M Kihlgren, and W Lehmann, and A Lekman, and J E Månsson, and I Ramström, and A Wallin, and C Wikkelsö, and C G Gottfries, and L Svennerholm
Parenteral administration of GM1 ganglioside to presenile Alzheimer patients.
January 1990, Acta neurologica Scandinavica,
L E Augustinsson, and K Blennow, and C Blomstrand, and G Bråne, and R Ekman, and P Fredman, and I Karlsson, and M Kihlgren, and W Lehmann, and A Lekman, and J E Månsson, and I Ramström, and A Wallin, and C Wikkelsö, and C G Gottfries, and L Svennerholm
Alzheimer disease - effect of continuous intracerebroventricular treatment with GM1 ganglioside and a systematic activation programme.
January 2002, Dementia and geriatric cognitive disorders,
L E Augustinsson, and K Blennow, and C Blomstrand, and G Bråne, and R Ekman, and P Fredman, and I Karlsson, and M Kihlgren, and W Lehmann, and A Lekman, and J E Månsson, and I Ramström, and A Wallin, and C Wikkelsö, and C G Gottfries, and L Svennerholm
Enhanced GM1 ganglioside catabolism in cultured fibroblasts from Alzheimer patients.
June 2005, Neurobiology of aging,
L E Augustinsson, and K Blennow, and C Blomstrand, and G Bråne, and R Ekman, and P Fredman, and I Karlsson, and M Kihlgren, and W Lehmann, and A Lekman, and J E Månsson, and I Ramström, and A Wallin, and C Wikkelsö, and C G Gottfries, and L Svennerholm
Pharmacokinetics of GM1 ganglioside following parenteral administration.
October 1990, The Journal of pharmacy and pharmacology,
L E Augustinsson, and K Blennow, and C Blomstrand, and G Bråne, and R Ekman, and P Fredman, and I Karlsson, and M Kihlgren, and W Lehmann, and A Lekman, and J E Månsson, and I Ramström, and A Wallin, and C Wikkelsö, and C G Gottfries, and L Svennerholm
Properties of antisera to ganglioside GM1 and asialo GM1.
July 1974, Journal of immunology (Baltimore, Md. : 1950),
L E Augustinsson, and K Blennow, and C Blomstrand, and G Bråne, and R Ekman, and P Fredman, and I Karlsson, and M Kihlgren, and W Lehmann, and A Lekman, and J E Månsson, and I Ramström, and A Wallin, and C Wikkelsö, and C G Gottfries, and L Svennerholm
GM1 ganglioside administration protects spinal neurons after glutamate excitotoxicity.
January 1999, Restorative neurology and neuroscience,
L E Augustinsson, and K Blennow, and C Blomstrand, and G Bråne, and R Ekman, and P Fredman, and I Karlsson, and M Kihlgren, and W Lehmann, and A Lekman, and J E Månsson, and I Ramström, and A Wallin, and C Wikkelsö, and C G Gottfries, and L Svennerholm
Antibodies to ganglioside GM1 in patients with Alzheimer's disease.
March 1988, Neuroscience letters,
L E Augustinsson, and K Blennow, and C Blomstrand, and G Bråne, and R Ekman, and P Fredman, and I Karlsson, and M Kihlgren, and W Lehmann, and A Lekman, and J E Månsson, and I Ramström, and A Wallin, and C Wikkelsö, and C G Gottfries, and L Svennerholm
[Effect of ganglioside GM1 on the metabolism of Alzheimer amyloid beta-protein precursor].
March 1998, Zhonghua yi xue za zhi,
L E Augustinsson, and K Blennow, and C Blomstrand, and G Bråne, and R Ekman, and P Fredman, and I Karlsson, and M Kihlgren, and W Lehmann, and A Lekman, and J E Månsson, and I Ramström, and A Wallin, and C Wikkelsö, and C G Gottfries, and L Svennerholm
Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review.
June 2019, Cell transplantation,
L E Augustinsson, and K Blennow, and C Blomstrand, and G Bråne, and R Ekman, and P Fredman, and I Karlsson, and M Kihlgren, and W Lehmann, and A Lekman, and J E Månsson, and I Ramström, and A Wallin, and C Wikkelsö, and C G Gottfries, and L Svennerholm
Formation of a cytosolic ganglioside-protein complex following administration of photoreactive ganglioside GM1 to human fibroblasts in culture.
April 1990, FEBS letters,
Copied contents to your clipboard!